ActualitésAssisté par IA

Samjin Pharm Donates Over ₩100 Million In Medicines In First Half Of The Year

Samjin Pharmaceuticals donates Geworin to underserved communities and disaster-hit regions globally.

Simantini Singh Deo
Par Simantini Singh Deo
Rédacteur principal de contenu
23 août 2024Updated Jun 26, 2025 · 2 min de lecture
Samjin Pharm Donates Over ₩100 Million In Medicines In First Half Of The Year
https://www.koreabiomed.com/news/articleView.html?idxno=23554
Journalisme assisté par IA
Reviewed by Simantini Singh Deo, Rédacteur principal de contenu

The company donated its flagship antipyretic and anti-inflammatory medication, Geworin (a combination of acetaminophen and isopropylantipyrine). As the second-largest pain relief product globally, trailing only Tylenol, Geworin holds the top spot in sales within Korea.

These medications have been supplied at no cost to underserved communities and free healthcare clinics for foreign workers in Korea through local charities like the Korea Foundation for International Healthcare, Soul Love People, and Good News World.

In addition, assistance has been extended to areas impacted by the recent Noto Peninsula earthquake in Japan, conflict-ridden Ukraine, and regions with limited medical resources, including Myanmar, Cambodia, and Malawi.

Choi Yong-ju, CEO of Samjin Pharmaceuticals, “We hope that this donation of medicines will help many regions struggling with inadequate medical infrastructure. We will continue to fulfill our corporate social responsibility by supporting vulnerable and marginalized groups through ongoing projects.”

Simantini Singh Deo
Written by
Simantini Singh Deo
Rédacteur principal de contenu

Simantini Singh Deo works on the latest and trending news happening daily in the pharma world.

Discussion

Chargement de la discussion…

Plus dans Pharma News

Tous les articles →